| [3] |
Vavricka SR，Schoepfer A，Scharl M，et al.Extraintestinal Manifestations of Inflammatory Bowel Disease[J].Inflamm Bowel Dis，2015，21（8）：1982-1992.
|
| [2] |
Zhang YZ，Li YY.Inflammatory bowel disease：pathogenesis[J].World J Gastroenterol，2014，20（1）：91-99.
|
| [1] |
Sairenji T，Collins KL，Evans DV.An Update on Inflammatory Bowel Disease[J].Prim Care，2017，44（4）：673-692.
|
| [4] |
Lichtenstein GR，Hanauer SB，Sandborn WJ，et al.Management of Crohn's disease in adults[J].Am J Gastroenterol，2009，104（2）：465-483.
|
| [5] |
Kornbluth A，Sachar DB，Practice Parameters Committee of the American College of Gastroenterology.Ulcerative colitis practice guidelines in adults：American College Of Gastroenterology，Practice Parameters Committee[J].Am J Gastroenterol，2010，105（3）：501-523.
|
| [6] |
Mowat C，Cole A，Windsor A，et al.Guidelines for the management of inflammatory bowel dis ease in adults[J].Gut，2011，60：571-607.
|
| [7] |
Hwang JM，Varma MG.Surgery for inflammatory bowel disease[J].World J Gastroenterol，2008，14（17）：2678-2690.
|
| [8] |
Binder V.Epidemiology of IBD during the twentieth century：an integrated view[J].Best Pract Res Clin Gastroenterol，2004，18（3）：463-479.
|
| [9] |
Kaplan GG.The global burden of IBD：from 2015 to 2025[J].Nat Rev Gastroenterol Hepatol，2015，12（12）：720-727.
|
| [10] |
Clarke DM，Currie KC.Depression，anxiety and their relationship with chronic diseases：a review of the epidemiology，risk and treatment evidence[J].Med J Aust，2009，190（7）：54-60.
|
| [11] |
Neuendorf R，Harding A，Stello N，et al.Depression and anxiety in patients with Inflammatory Bowel Disease：A systematic review[J].J Psychosom Res，2016，87：70-80.
|
| [12] |
Stapersma L，Brink G，Szigethy EM，et al.Systematic review with meta-analysis：anxiety and depression in children and adolescents with inflammatory bowel disease[J].Aliment Pharmacol Ther，2018，48（5）：496-506.
|
| [13] |
Costello EJ，Copeland W，Angold A.Trends in psychopathology across the adolescent years：what changes when children become adolescents，and when adolescents become adults?[J].J Child Psychol Psychiatry，2011，52（10）：1015-1025.
|
| [14] |
Abautret-Daly á，Dempsey E，Parra-Blanco A，et al.Gutbrain actions underlying comorbid anxiety and depression associated with inflammatory bowel disease[J].Acta Neuropsychiatr，2018，30（5）：275-296.
|
| [15] |
Geiss T，Schaefert RM，Berens S，et al.Risk of depression in patients with inflammatory bowel disease[J].J Dig Dis，2018，19（8）：456-467.
|
| [16] |
Horst S，Chao A，Rosen M，et al.Treatment with immunosuppressive therapy may improve depressive symptoms in patients with inflammatory bowel disease[J].Dig Dis Sci，2015，60（2）：465-470.
|
| [34] |
Lapin IP.Neurokynurenines （NEKY） as common neurochemical links of stress and anxiety[J].Adv Exp Med Biol，2003，527：121-125.
|
| [39] |
Yirmiya R.Endotoxin produces a depressive-like episode in rats[J].Brain Res，1996，711（1-2）：163-174.
|
| [41] |
Zhang YZ，Li YY.Inflammatory bowel disease：pathogenesis[J].World J Gastroenterol，2014，20（1）：91-99.
|
| [51] |
Rapozo DC，Bernardazzi C，de Souza HS.Diet and microbiota in inflammatory bowel disease：The gut in disharmony[J].World J Gastroenterol，2017 23（12）：2124-2140.
|
| [17] |
Alexakis C，Kumar S，Saxena S，et al.Systematic review with meta-analysis：the impact of a depressive state on disease course in adult inflammatory bowel disease[J].Aliment Pharmacol Ther，2017，46（3）：225-235.
|
| [18] |
Vidal A，Gómez-Gil E，Sans M，et al.The impact of anxiety and depression on relapse in patients with inflammatory bowel disease[J].Med Clin （Barc），2009，132（8）：298-302.
|
| [19] |
Mikocka-Walus A，Pittet V，Rossel JB，et al.Symptoms of Depression and Anxiety Are Independently Associated With Clinical Recurrence of Inflammatory Bowel Disease[J].Clin Gastroenterol Hepatol，2016，14（6）：829-835.
|
| [20] |
Goldsmith DR，Rapaport MH，Miller BJ.A meta-analysis of blood cytokine network alterations in psychiatric patients：comparisons between schizophrenia，bipolar disorder and depression[J].Mol Psychiatry，2016，21（12）：1696-1709.
|
| [21] |
Margaretten M，Julian L，Katz P，et al.Depression in patients with rheumatoid arthritis：description，causes and mechanisms[J].Int J Clin Rheumatol，2011，6（6）：617-623.
|
| [22] |
Hare DL，Toukhsati SR，Johansson P，et al.Depression and cardiovascular disease：a clinical review[J].Eur Heart J，2014，35（21）：1365-1372.
|
| [23] |
Andreoulakis E，Hyphantis T，Kandylis D，et al.Depression in diabetes mellitus：a comprehensive review[J].Hippokratia，2012，16（3）：205-214.
|
| [24] |
Martin-Subero M，Anderson G，Kanchanatawan B，et al.Comorbidity between depression and inflammatory bowel disease explained by immune-inflammatory，oxidative，and nitrosative stress；tryptophan catabolite；and gut -brain pathways[J].CNS Spectr，2016，21（2）：184-198.
|
| [25] |
Abautret-Daly á，Dempsey E，Riestra S，et al.Association between psychological measures with inflammatory anddisease-related markers of inflammatory bowel disease[J].Int J Psychiatry Clin Pract，2017，21（3）：221-230.
|
| [26] |
Kiss LS，Szamosi T，Molnar T，et al.Early clinical remission and normalisation of CRP are the strongest predictors of efficacy，mucosal healing and dose escalation during the first year of adalimumab therapy in Crohn's disease[J].Aliment Pharmacol Ther，2011，34（8）：911-922.
|
| [27] |
Kiss LS，Papp M，Lovasz BD，et al.High-sensitivity C-reactive protein for identification of disease phenotype，active disease，and clinical relapses in Crohn's disease：a marker for patient classification[J]Inflamm Bowel Dis，2012，18（9）：1647-1654.
|
| [28] |
Pasco JA，Nicholson GC，Williams LJ，et al.Association of high-sensitivity C-reactive protein with de novo major depression[J].Br J Psychiatry，2010，197（5）：372-377.
|
| [29] |
Hsuchou H，Kastin AJ，Mishra PK，et al.C-reactive protein increases BBB permeability：implications for obesity and neuroinflammation[J].Cell Physiol Biochem，2012，30（5）：1109-1119.
|
| [30] |
Zhu H，Li YR.Oxidative stress and redox signaling mechanisms of inflammatory bowel disease：updated experimental and clinical evidence[J].Exp Biol Med （Maywood），2012，237（5）：474-480.
|
| [31] |
Rachmilewitz D，Stamler JS，Karmeli F，et al.Peroxynitriteinduced rat colitis——a new model of colonic inflammation[J].Gastroenterology，1993，105（6）：1681-1688.
|
|
[32 Leonard B，Maes M.Mechanistic explanations how cell-mediated immune activation，inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression[J] Neurosci Biobehav Rev，2012，36（2）：764-785.
|
| [33] |
Bian Y，Zhao X，Li M，et al.Various roles of astrocytes during recovery from repeated exposure to different doses of lipopolysaccharide[J].Behav Brain Res，2013，253：253-261.
|
| [35] |
O'Connor JC，Lawson MA，André C，et al.Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice[J].Mol Psychiatry，2009，14（5）：511-522.
|
| [36] |
Oxenkrug GF.Genetic and hormonal regulation of tryptophan kynurenine metabolism：implications for vascular cognitive impairment，major depressive disorder，and aging[J].Ann N Y Acad Sci，2007，1122：35-49.
|
| [37] |
Maes M，Kubera M，Leunis，et al.The gut-brain barrier in major depression：intestinal mucosal dysfunction with an increased translocation of LPS from gram negative enterobacteria（leaky gut）plays a role in the inflammatory pathophysiology of depression[J].Neuro Endocrinol Lett，2008，29（1）：117-124.
|
| [38] |
Maes M，Kubera M，Leunis JC，et al.In depression，bacterial translocation may drive inflammatory responses，oxidative and nitrosative stress （O&NS），and autoimmune responses directed against O&NS-damaged neoepitopes[J].Acta Psychiatr Scand，2013，127（5）：344-354.
|
| [40] |
De La Garza R 2nd.Endotoxin-or pro-inflammatory cytokine-induced sickness behavior as an animal model of depression：focus on anhedonia[J].Neurosci Biobehav Rev，2005，29（4-5）：761-770.
|
| [42] |
Gassler N，Rohr C，Schneider A，et al.Inflammatory bowel disease is associated with changes of enterocytic junctions[J].Am J Physiol Gastrointest Liver Physiol，2001，281（1）：G216-228.
|
| [43] |
Lepage P，Hasler R，Spehlmann ME，et al.Twin study indicates loss of interaction between microbiota and mucosa of patients with ulcerative colitis[J].Gastroenterology，2011，141（1）：227-236.
|
| [44] |
Lawson MA，Parrott JM，McCusker RH，et al.Intracerebroventricular administration of lipopolysaccharide induces indoleamine-2，3-dioxygenase-dependent depression-like behaviors[J].J Neuroinflammation，2013，10：87.
|
| [45] |
Doenlen R，Krügel U，Wirth T，et al.Electrical activity in rat cortico-limbic structures after single or repeated administration of lipopolysaccharide or staphylococcal enterotoxin B[J].Proc Biol Sci，2011，278（1713）：1864-1872.
|
| [46] |
Haba R，Shintani N，Onaka Y，et al.Lipopolysaccharide affects exploratory behaviors toward novel objects by impairing cognition and/or motivation in mice：Possible role of activation of the central amygdala[J].Behav Brain Res，2012，228（2）：423-431.
|
| [47] |
Nahon S，Lahmek P，Durance C，et al.Risk factors of anxiety and depression in inflammatory bowel disease[J].Inflamm Bowel Dis，2012，18（11）：2086-2091.
|
| [48] |
Navabi S，Gorrepati VS，Yadav S，et al.Influences and Impact of Anxiety and Depression in the Setting of Inflammatory Bowel Disease[J].Inflamm Bowel Dis，2018，24（11）：2303-2308.
|
| [49] |
Keightley P，Reay RE，Pavli P，et al.Inflammatory bowel disease-related fatigue is correlated with depression and gender[J].Australas Psychiatry，2018，26（5）：508-513.
|
| [50] |
Hou JK，Abraham B，El-Serag H.Dietary intake and risk of developing inflammatory bowel disease：a systematic review of the literature[J].Am J Gastroenterol，2011，106（4）：563-573.
|
| [52] |
Messaoudi M，Lalonde R，Violle N，et al.Assessment of psychotropic-like properties of a probiotic formulation （Lactobacillus helveticus R0052 and Bifidobacterium longum R0175）in rats and human subjects[J].Br J Nutr 2011，105（5）：755-764.
|
| [53] |
Konturek PC，Konturek K，Zopf Y.Stress und chronischentzündliche Darmerkrankungen [Stress and inflammatory bowel disease][J].MMW Fortschr Med，2020，162 （Suppl 5）：3-6.
|
| [54] |
Brzozowski B，Mazur-Bialy A，Pajdo R，et al.Brzozowski T.Mechanisms by which Stress Affects the Experimental and Clinical Inflammatory Bowel Disease （IBD）：Role of Brain-Gut Axis[J].Curr Neuropharmacol，2016，14（8）：892-900.
|
| [55] |
Goodhand JR，Wahed M，Mawdsley JE，et al.Mood disorders in inflammatory bowel disease：relation to diagnosis，disease activity，perceived stress，and other factors[J].Inflamm Bowel Dis，2012，18（12）：2301-2309.
|
| [56] |
Schuman SL，Graef DM，Janicke DM，et al.An exploration of family problem-solving and affective involvement as moderators between disease severity and depressive symptoms in adolescents with inflammatory bowel disease[J].J Clin Psychol Med Settings，2013，20（4）：488-496.
|
| [57] |
Abraham BP，Ahmed T，Ali T.Inflammatory Bowel Disease：Pathophysiology and Current Therapeutic Approaches[J].Handb Exp Pharmacol，2017，239：115-146.
|
| [58] |
Frolkis AD，Vallerand IA，Shaheen AA，et al.Depression increases the risk of inflammatory bowel disease，which may be mitigated by the use of antidepressants in the treatment of depression[J].Gut，2019，68（9）：1606-1612.
|
| [59] |
Goodhand JR，Greig FI，Koodun Y，et al.Do antidepressants influence the disease course in inflammatory bowel disease?A retrospective case-matched observational study[J].Inflamm Bowel Dis 2012，18（7）：1232-1239.
|
| [60] |
van den Brink G Stapersma L，Bom AS，et al.Effect of Cognitive Behavioral Therapy on Clinical Disease Course in Adolescents and Young Adults With Inflammatory Bowel Disease and Subclinical Anxiety and/or Depression：Results of a Randomized Trial[J].Inflamm Bowel Dis，2019，25（12）：1945-1956.
|
| [61] |
Wynne B，McHugh L，Gao W，et al.Acceptance and Commitment Therapy Reduces Psychological Stress in Patients With Inflammatory Bowel Diseases[J].Gastroenterology，2019，156（4）：935-945.
|
